FYARRO
NDC 80803-153, Sirolimus, injection, powder, lyophilized, for suspension, from Aadi Bioscience, Inc..
- Product NDC
- 80803-153
- Status
- Listed
- Labeler
- Aadi Bioscience, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213312
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80803-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIROLIMUS5 mg/mL
Pharmacologic classes
Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80803-153-50 | 80803015350 | 1 VIAL, SINGLE-USE in 1 CARTON (80803-153-50) / 20 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f9bb784-53e2-46f9-a65d-1c6c2a230eafMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=80803-153
Use it
Look up 80803-153 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80803-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80803-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.